Effects of legal and illegal use of benzodiazepines at acute admission to a psychiatric acute department

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Fløvig, John C ^a,b   Vaaler, Arne E ^a,b   Morken, Gunnar ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957904805     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-263     Document Type: Article

References (26)

1. Substance abuse and emergency psychiatry. JJ Zealberg KT Brady, Psychiatr Clin North Am 1999 22 803 817 10.1016/S0193-953X(05)70127-1 10623972
2. Managing the acutely agitated and psychotic patient. K Nordstrom MH Allen, CNS Spectr 2007 12 5 11 17934384
3. Catatonia: a review. ND Weder S Muralee H Penland RR Tampi, Ann Clin Psychiatry 2008 20 97 107 18568581
4. Treatment of behavioral emergencies: a summary of the expert consensus guidelines. MH Allen GW Currier DH Hughes JP Docherty D Carpenter R Ross, J Psychiatr Pract 2003 9 16 38 10.1097/00131746-200301000-00004 15985913
5. Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial. S Wilhelm A Schacht T Wagner, BMC Psychiatry 2008 8 61 10.1186/1471-244X-8-61 18647402
6. Pharmacological management of agitation in emergency settings. A Yildiz GS Sachs A Turgay, Emerg Med J 2003 20 339 346 10.1136/emj.20.4.339 12835344
7. The strong relationship between bipolar and substance-use disorder. AC Swann, Ann N Y Acad Sci 2010 1187 276 293 10.1111/j.1749-6632.2009.05146.x 20201858
8. Mental disorders associated with benzodiazepine use among older primary care attenders - A regional survey. M Balestrieri G Marcon F Samani M Marini E Sessa U Gelatti F Donato, Soc Psychiatry Psychiatr Epidemiol 2005 40 308 315 10.1007/s00127-005-0899-9 15834782
9. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). K Demyttenaere A Bonnewyn R Bruffaerts GG De I Gasquet V Kovess JM Haro J Alonso, J Affect Disord 2008 110 84 93 10.1016/j.jad.2008.01. 011 18329721
10. Benzodiazepine dependence. RP Swinson JC Pecknold ME Kirby, J Affect Disord 1987 13 109 118 10.1016/0165-0327(87)90016-4 2890676
11. Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence. J Mordal JG Bramness B Holm J Morland, Gen Hosp Psychiatry 2008 30 55 60 10.1016/j.genhosppsych.2007. 10.006 18164941
12. Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening. C Bonsack D Camus N Kaufmann AC Aubert J Besson P Baumann F Borgeat M Gillet CB Eap, Addict Behav 2006 31 1252 1258 10.1016/j.addbeh.2005.08.008 16137835
13. Substance use at admission to an acute psychiatric department. JC Flovig AE Vaaler G Morken, Nord J Psychiatry 2009 63 113 119 10.1080/08039480802294787 18991157
14. Substance abuse and recovery in a Psychiatric Intensive Care Unit. AE Vaaler G Morken JC Flovig VC Iversen OM Linaker, Gen Hosp Psychiatry 2006 28 65 70 10.1016/j.genhosppsych.2005.08.009 16377368
15. Acute mental health admissions in inner London: Changes in patient characteristics and clinical admission thresholds between 1988 and 1998. NK Fitzpatrick CJ Thompson H Hemingway TRE Barnes A Higgitt C Molloy S Hargreaves, Psychiatric Bulletin 2003 27 7 11 10.1192/pb.27.1.7 (Pubitemid 36090053)
16. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. N Magrini A Vaccheri E Parma R D'Alessandro A Bottoni M Occhionero N Montanaro, Eur J Clin Pharmacol 1996 50 19 25 10.1007/s002280050063 8739806
17. Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. R van Hulten HG Leufkens A Bakker, Pharm World Sci 1998 20 78 82 10.1023/A:1008636707219 9584341
18. United Nations Convention on Psychotropic Substances. 1971 http://www.unodc.org/pdf/convention-1971-en.pdf
19. World Health Organization, The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research Geneva, Switzerland: WHO 1993
20. Global Assessment of Functioning (GAF) scale. Diagnostic and Statistical Manual of Mental Disorders Washington DC: American Psychiatric Association 4 1994
21. Generalizability studies of the Global Assessment of Functioning-Split version. G Pedersen KA Hagtvet S Karterud, Compr Psychiatry 2007 48 88 94 10.1016/j.comppsych.2006.03.008 17145287
22. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. S Derry RA Moore, BMC Psychiatry 2007 7 40 10.1186/1471-244X-7-40 17705840
23. The efficacy of divalproex sodium in the treatment of agitation associated with major depression. C DeBattista A Solomon B Arnow E Kendrick J Tilston AF Schatzberg, J Clin Psychopharmacol 2005 25 476 479 10.1097/01.jcp.0000177552.21338.b0 16160625
24. Agitated "unipolar" major depression: prevalence, phenomenology, and outcome. M Maj R Pirozzi L Magliano A Fiorillo L Bartoli, J Clin Psychiatry 2006 67 712 719 10.4088/JCP.v67n0504 16841620
25. Pharmacological management of acute agitation. J Battaglia, Drugs 2005 65 1207 1222 10.2165/00003495-200565090-00003 15916448
26. Managing the agitated psychotic patient: a reappraisal of the evidence. MH Allen, J Clin Psychiatry 2000 61 Suppl 14 11 20 11154012